Harpoon Therapeutics, Inc. is a clinical-stage an immuno-oncology company, and its proprietary antibody-based drug discovery platform is called TriTAC, which offers a new way to unleash the target cell-killing properties of a patient's own immune system.
from RTT - Biotech http://bit.ly/2D73jyY
via IFTTT
No comments:
Post a Comment